Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 8-K Event Shareholder vote results
  7. 4 Open-market buy President and CEO bought 12,000 shares at an average $3.41 ($40,874)
  8. 4 Open-market buy President and CEO bought 15,212 shares at an average $3.49 ($53,039)
  9. 4 Open-market buy Chief Financial Officer bought 25,500 shares at an average $3.49 ($88,980)
  10. 8-K Event Regulation FD disclosure · Other events
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. DEFA14A Proxy Proxy Materials
  15. DEF 14A Proxy Proxy Statement
  16. 10-K Report Annual Report
  17. 8-K Event Results of operations
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G Stake Amended Statement of Ownership
  20. SC 13G/A Stake Amended Statement of Ownership

Page 19 of 30 · 584 filings